0000905718-19-000894.txt : 20191101 0000905718-19-000894.hdr.sgml : 20191101 20191101063338 ACCESSION NUMBER: 0000905718-19-000894 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191101 DATE AS OF CHANGE: 20191101 EFFECTIVENESS DATE: 20191101 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Zyversa Therapeutics, Inc. CENTRAL INDEX KEY: 0001613083 IRS NUMBER: 465188564 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-352367 FILM NUMBER: 191185112 BUSINESS ADDRESS: STREET 1: 2200 N. COMMERCE PARKWAY STREET 2: SUITE 200 CITY: WESTON STATE: FL ZIP: 33326 BUSINESS PHONE: 954-931-2075 MAIL ADDRESS: STREET 1: 2200 N. COMMERCE PARKWAY STREET 2: SUITE 200 CITY: WESTON STATE: FL ZIP: 33326 FORMER COMPANY: FORMER CONFORMED NAME: Zyversa Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20191031 FORMER COMPANY: FORMER CONFORMED NAME: Variant Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20140708 D 1 primary_doc.xml X0708 D LIVE 0001613083 Zyversa Therapeutics, Inc. 2200 N. COMMERCE PARKWAY SUITE 200 WESTON FL FLORIDA 33326 646-414-6965 FLORIDA None Zyversa Pharmaceuticals, Inc. Variant Pharmaceuticals, Inc. Corporation true Stephen C Glover 2200 N. Commerce Parkway Suite 200 Weston FL FLORIDA 33326 Executive Officer Director Robert Finizio 2200 N. Commerce Parkway Suite 200 Weston FL FLORIDA 33326 Director Anthony Giovinazzo 2200 N. Commerce Parkway Suite 200 Weston FL FLORIDA 33326 Director Eric Richman 2200 N. Commerce Parkway Suite 200 Weston FL FLORIDA 33326 Director Andrew Kim 2200 N. Commerce Parkway Suite 200 Weston FL FLORIDA 33326 Director Aaron Greenblatt 2200 N. Commerce Parkway Suite 200 Weston FL FLORIDA 33326 Director Jules Musing 2200 N. Commerce Parkway Suite 200 Weston FL FLORIDA 33326 Director Pharmaceuticals Decline to Disclose 06b false 2019-10-22 false true true true Notes Convertible into common stock false 0 Craft Capital Management LLC 171350 None None 377 OAK STREET STE. 402 GARDEN CITY NY NEW YORK 11530 AK ALASKA AZ ARIZONA CA CALIFORNIA CO COLORADO CT CONNECTICUT FL FLORIDA GA GEORGIA HI HAWAII ID IDAHO IL ILLINOIS IN INDIANA IA IOWA KS KANSAS KY KENTUCKY LA LOUISIANA MD MARYLAND MI MICHIGAN MN MINNESOTA MS MISSISSIPPI MO MISSOURI MT MONTANA NE NEBRASKA NV NEVADA NJ NEW JERSEY NM NEW MEXICO NY NEW YORK NC NORTH CAROLINA ND NORTH DAKOTA OH OHIO OK OKLAHOMA OR OREGON PA PENNSYLVANIA RI RHODE ISLAND SC SOUTH CAROLINA SD SOUTH DAKOTA TN TENNESSEE TX TEXAS UT UTAH VA VIRGINIA WA WASHINGTON WV WEST VIRGINIA WI WISCONSIN WY WYOMING PR PUERTO RICO false Noble Life Science Partners 15768 None None 225 NE MIZNER BOULEVARD SUITE 150 BOCA RATON FL FLORIDA 33432 AL ALABAMA AK ALASKA AZ ARIZONA AR ARKANSAS CA CALIFORNIA CO COLORADO CT CONNECTICUT DE DELAWARE DC DISTRICT OF COLUMBIA FL FLORIDA GA GEORGIA HI HAWAII ID IDAHO IL ILLINOIS IN INDIANA IA IOWA KS KANSAS KY KENTUCKY LA LOUISIANA MD MARYLAND MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA MS MISSISSIPPI MO MISSOURI NV NEVADA NH NEW HAMPSHIRE NJ NEW JERSEY NY NEW YORK NC NORTH CAROLINA ND NORTH DAKOTA OH OHIO OK OKLAHOMA OR OREGON PA PENNSYLVANIA RI RHODE ISLAND SC SOUTH CAROLINA TN TENNESSEE TX TEXAS UT UTAH VT VERMONT VA VIRGINIA WA WASHINGTON WV WEST VIRGINIA WI WISCONSIN WY WYOMING false 20000000 1277500 18722500 false 19 1625000 true 0 Assumes maximum commissions earned. 0 true Some of the proceeds may be used for general working capital purposes, including the payment of salaries and other fees to those listed in Item 3. false Zyversa Therapeutics, Inc. /s/ Stephen C. Glover Stephen C. Glover CEO 2019-11-01